Published in Mol Diagn on January 01, 2004
Large scale multiplex PCR improves pathogen detection by DNA microarrays. BMC Microbiol (2009) 1.01
Evaluation of a viral microarray based on simultaneous extraction and amplification of viral nucleotide acid for detecting human herpesviruses and enteroviruses. PLoS One (2015) 0.77
Individual sequences in large sets of gene sequences may be distinguished efficiently by combinations of shared sub-sequences. BMC Bioinformatics (2005) 0.75
Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med (2011) 4.46
Prevalence of PB1-F2 of influenza A viruses. J Gen Virol (2007) 1.88
Varicella vaccination in Europe - taking the practical approach. BMC Med (2009) 1.63
Phylogenetics, evolution, and medical importance of polyomaviruses. Infect Genet Evol (2009) 1.46
Association of Stress Coping Strategies with Immunological Parameters in Melanoma Patients. Acta Derm Venereol (2016) 1.39
The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Vaccine (2011) 1.35
Sequencing of porcine enterovirus groups II and III reveals unique features of both virus groups. J Virol (2002) 1.34
Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication. J Antimicrob Chemother (2005) 1.32
High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J Gen Virol (2009) 1.30
Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis (2008) 1.28
Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Med Microbiol Immunol (2011) 1.28
Mouse heart Na+ channels: primary structure and function of two isoforms and alternatively spliced variants. Am J Physiol Heart Circ Physiol (2002) 1.23
Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination. J Virol (2011) 1.16
Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol (2010) 1.12
Novel reassortant of swine influenza H1N2 virus in Germany. J Gen Virol (2008) 1.12
Molecular-based reclassification of the bovine enteroviruses. J Gen Virol (2006) 1.10
Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay. Antiviral Res (2004) 1.09
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health (2007) 1.08
Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J (2013) 1.04
Isolation and molecular characterization of a second serotype of the encephalomyocarditis virus. Vet Microbiol (2012) 1.02
Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster. J Clin Microbiol (2004) 1.02
Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication. J Med Chem (2007) 1.02
Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein. J Med Chem (2008) 1.01
Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J Med Chem (2010) 1.01
The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ (2004) 1.00
Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease. J Med Virol (2008) 1.00
Per aspera ad astra: application of Simplex QSAR approach in antiviral research. Future Med Chem (2010) 0.98
Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001. Intervirology (2006) 0.98
Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. J Antimicrob Chemother (2005) 0.97
Prevalence of BK virus subtype I in Germany. J Med Virol (2006) 0.97
Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test. Clin Vaccine Immunol (2012) 0.96
Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany. Med Microbiol Immunol (2013) 0.95
Evolution of four BK virus subtypes. Infect Genet Evol (2008) 0.95
Homology modelling: a review about the method on hand of the diabetic antigen GAD 65 structure prediction. Wien Med Wochenschr (2009) 0.95
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ (2014) 0.94
Influenza A virus PB1-F2 gene. Emerg Infect Dis (2006) 0.93
Virus diagnostics on microarrays. Curr Pharm Biotechnol (2003) 0.93
Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir. Mutat Res (2002) 0.91
N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J Virol (2006) 0.91
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis (2014) 0.90
Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. Antiviral Res (2003) 0.90
Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy. Epilepsia (2006) 0.90
Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany. Med Microbiol Immunol (2014) 0.90
Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2. Antivir Ther (2011) 0.90
Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3. Viral Immunol (2005) 0.89
Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006. Antiviral Res (2009) 0.88
Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes. Viral Immunol (2010) 0.87
Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004. Med Klin (Munich) (2005) 0.87
Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008. Med Microbiol Immunol (2011) 0.86
Poly(rC)-binding protein 2 interacts with the oligo(rC) tract of coxsackievirus B3. Biochem Biophys Res Commun (2007) 0.86
Anti-coxsackievirus B3 activity of 2-amino-3-nitropyrazolo[1,5-a]pyrimidines and their analogs. Bioorg Med Chem Lett (2005) 0.85
DNA microarray analysis: principles and clinical impact. Hematology (2007) 0.85
Ongoing evolution of swine influenza viruses: a novel reassortant. Arch Virol (2008) 0.85
Age-related and regional differences in the prevalence of hepatitis E virus-specific antibodies in pigs in Germany. Vet Microbiol (2013) 0.85
Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity. Emerg Infect Dis (2010) 0.85
Laser scanning confocal fluorescence microscopy: an overview. Int Immunopharmacol (2003) 0.84
Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3. Apoptosis (2007) 0.84
Prevalence of antibodies to swine influenza viruses in humans with occupational exposure to pigs, Thuringia, Germany, 2008-2009. J Med Virol (2010) 0.84
New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3. Antiviral Res (2008) 0.84
Linkage map of protein-protein interactions of Porcine teschovirus. J Gen Virol (2005) 0.84
Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs. PLoS One (2013) 0.83
Do children and adolescents with type 1 diabetes mellitus have a higher frequency of parietal cell antibodies than healthy controls? J Pediatr Gastroenterol Nutr (2011) 0.83
Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury. J Med Virol (2010) 0.83
Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen. Clin Lab (2009) 0.83
Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis. Vaccine (2007) 0.83
Genotyping of varicella-zoster virus strains after serial passages in cell culture. J Virol Methods (2007) 0.83
Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy. Med Microbiol Immunol (2003) 0.83
Fatal outcome of herpes simplex virus type 1-induced necrotic hepatitis in a neonate. Med Microbiol Immunol (2006) 0.82
Resistance testing of clinical varicella-zoster virus strains. Antiviral Res (2011) 0.82
Enhancing sensitivity of human herpes virus diagnosis with DNA microarrays using dendrimers. Exp Mol Pathol (2004) 0.82
Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus. Antivir Ther (2011) 0.82
Simvastatin treatment showed no prophylactic effect in influenza virus-infected mice. J Med Virol (2013) 0.82
Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antiviral Res (2003) 0.82
Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication. Arch Virol (2011) 0.82
Detection of graphite using laser microprobe mass analysis of a transbronchial biopsy from a foundry worker with mixed dust pneumoconiosis. Wien Klin Wochenschr (2002) 0.81
Vaccination procedures against Coxsackievirus-induced heart disease. Expert Rev Vaccines (2003) 0.81
Impact of global warming on viral diseases: what is the evidence? Curr Opin Biotechnol (2008) 0.81
[From pneumonic infiltration to parapneumonic effusion--from effusion to pleural empyema: internal medicine aspects of parapneumonic effusion development and pleural empyema]. Wien Med Wochenschr (2003) 0.81
Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance. Antiviral Res (2012) 0.81
Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8. Mol Pharmacol (2003) 0.81
Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients. Med Microbiol Immunol (2012) 0.81
Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections. Intervirology (2006) 0.81
QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3. Future Med Chem (2011) 0.80
Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999. Antiviral Res (2007) 0.80
Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2. J Virol Methods (2007) 0.80
Analysis of varicella-zoster virus and herpes simplex virus in various clinical samples by the use of different PCR assays. J Virol Methods (2009) 0.80
CycloSal-BVDUMP pronucleotides: how to convert an antiviral-inactive nucleoside analogue into a bioactive compound against EBV. J Med Chem (2002) 0.80
Testing of herpes simplex virus for resistance to antiviral drugs. Virulence (2010) 0.79
Inhibitory efficacy of cyclosal-nucleoside monophosphates of aciclovir and brivudin on DNA synthesis of orthopoxvi ruses. Antivir Chem Chemother (2006) 0.78
Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds. Arzneimittelforschung (2004) 0.78